Literature DB >> 5690034

Hematoporphyrin-derivative fluorescence in malignant neoplasms.

H B Gregorie, E O Horger, J L Ward, J F Green, T Richards, H C Robertson, T B Stevenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5690034      PMCID: PMC1387148          DOI: 10.1097/00000658-196806000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  12 in total

1.  PRELIMINARY OBSERVATIONS IN A CLINICAL STUDY OF HEMATOPORPHYRIN-DERIVATIVE FLUORESCENCE IN MALIGNANT NEOPLASMS.

Authors:  H B GREGORIE; T B STEVENSON; H C ROBERTSON; J L WARD
Journal:  Am Surg       Date:  1964-10       Impact factor: 0.688

2.  Localization of a halogenated porphyrin in mouse tumours.

Authors:  K I ALTMAN; K SALOMON
Journal:  Nature       Date:  1960-09-24       Impact factor: 49.962

3.  FURTHER EVALUATION OF THE USE OF HEMATOPORPHYRIN DERIVATIVE AS A NEW AID FOR THE ENDOSCOPIC DETECTION OF MALIGNANT DISEASE.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  Dis Chest       Date:  1964-12

4.  Mechanisms involved in the production of red fluorescence of human and experimental tumours.

Authors:  F N GHADIALLY; W J NEISH; H C DAWKINS
Journal:  J Pathol Bacteriol       Date:  1963-01

5.  Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration.

Authors:  J WINKELMAN; D S RASMUSSEN-TAXDAL
Journal:  Bull Johns Hopkins Hosp       Date:  1960-10

6.  The use of a derivative of hematoporhyrin in tumor detection.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Natl Cancer Inst       Date:  1961-01       Impact factor: 13.506

7.  Porphyrin III staining of "malignolipin" in tumors.

Authors:  P E HUGHES
Journal:  Stain Technol       Date:  1960-01

8.  Attempts at tumor localization using Cu 64-labeled copper porphyrins.

Authors:  R BASES; S S BRODIE; S RUBENFELD
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

9.  A new phospholipid, malignolipin, in human malignant tumors.

Authors:  T KOSAKI; T IKODA; Y KOTANI; S NAKAGAWA; T SAKA
Journal:  Science       Date:  1958-05-16       Impact factor: 47.728

10.  Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Thorac Cardiovasc Surg       Date:  1961-11       Impact factor: 5.209

View more
  22 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

3.  The in vivo localization of porphyrins.

Authors:  D S Barker; R W Henderson; E Storey
Journal:  Br J Exp Pathol       Date:  1970-12

Review 4.  Phototherapy in tumors.

Authors:  S G Bown
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

5.  Haematoporphyrin diacetate: a probe to distinguish malignant from normal tissue by selective fluorescence.

Authors:  R W Henderson; G S Christie; P S Clezy; J Lineham
Journal:  Br J Exp Pathol       Date:  1980-08

6.  Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative.

Authors:  J R Spears; J Serur; D Shropshire; S Paulin
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  Limited-angle x-ray luminescence tomography: methodology and feasibility study.

Authors:  C M Carpenter; G Pratx; C Sun; L Xing
Journal:  Phys Med Biol       Date:  2011-05-23       Impact factor: 3.609

8.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

9.  Photodynamic therapy for malignant tumours of the ampulla of Vater.

Authors:  A M Abulafi; J T Allardice; N S Williams; N van Someren; C P Swain; C Ainley
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

10.  Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients.

Authors:  T Patrice; M T Foultier; S Yactayo; F Adam; J P Galmiche; M C Douet; L Le Bodic
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.